High Density Lipoproteins : From Biological Understanding to Clinical Exploitation
High Density Lipoproteins : From Biological Understanding to Clinical Exploitation
edited by Arnold von Eckardstein, Dimitris Kardassis.
- 1 recurso en línea (XIII, 694 p.) 40 ilustraciones, 37 ilustraciones en color
- Handbook of Experimental Pharmacology 224 0171-2004 .
- Handbook of Experimental Pharmacology 224 .
Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
Open Access
In this Handbook of Experimental Pharmacology on “High Density Lipoproteins â€om biological understanding to clinical exploitationâ€ntributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusingÂlipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
9783319096650
10.1007/978-3-319-09665-0 doi
Lipoproteínas
QP99.3.H53 / 2015 EB
Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
Open Access
In this Handbook of Experimental Pharmacology on “High Density Lipoproteins â€om biological understanding to clinical exploitationâ€ntributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusingÂlipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
9783319096650
10.1007/978-3-319-09665-0 doi
Lipoproteínas
QP99.3.H53 / 2015 EB